Beneficial renal effect of insulin glargine 300 U/ml initiation in type 2 diabetes mellitus patients previously treated with insulin

被引：0
|
作者：
Popovic, D. S. [1 ,2 ]
Lelik-Tubic, K. [3 ]
机构：
[1] Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[2] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[3] Healthcare Ctr Alibunar, Alibunar, Serbia
来源：
DIABETES STOFFWECHSEL UND HERZ | 2020年 / 29卷 / 06期
关键词：
DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / +
页数：3
相关论文
共 50 条
  • [41] A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus
    Woo, Vincent C.
    CLINICAL THERAPEUTICS, 2017, 39 (08) : S12 - S33
  • [42] Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
    Steinstraesser, A.
    Schmidt, R.
    Bergmann, K.
    Dahmen, R.
    Becker, R. H. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 873 - 876
  • [43] Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats
    Saini, N. K.
    Wasik, B.
    Pires, J.
    Leale, D. M.
    Quach, N.
    Culp, W. T. N.
    Samms, R. J.
    Johnson, A. E.
    Owens, J. G.
    Gilor, C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2021, 75
  • [44] IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES
    Visentin, R.
    Schiavon, M.
    Giegerich, C.
    Sieber, J.
    Man, C. Dalla
    Cobelli, C.
    Klabunde, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A18 - A18
  • [45] Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
    Stewart B. Harris
    Erika B. Parente
    Janaka Karalliedde
    Diabetes Therapy, 2022, 13 : 913 - 930
  • [46] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
    Seufert, J.
    Fritsche, A.
    Anderten, H.
    Pegelow, K.
    Pscherer, S.
    Pfohl, M.
    DIABETOLOGIA, 2018, 61 : S441 - S441
  • [47] Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies
    Harris, Stewart B.
    Parente, Erika B.
    Karalliedde, Janaka
    DIABETES THERAPY, 2022, 13 (05) : 913 - 930
  • [48] EASE OF USE OF THE NEW INSULIN GLARGINE 300 U/ML PEN INJECTOR IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES
    Pohlmeier, H.
    Klonoff, D.
    Berard, L.
    Brulle-Wohlhueter, C.
    Wu, J.
    Dahmen, R.
    Nowotny, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A18 - A19
  • [49] Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naive people with type 2 diabetes: The EDITION AP randomized controlled trial
    Ji, Linong
    Kang, Eun Seok
    Dong, XiaoLin
    Li, Ling
    Yuan, GuoYue
    Shang, Shuhua
    Niemoeller, Elisabeth
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 612 - 621
  • [50] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
    Joshi, Shashank R.
    Singh, Gursharan
    Marwah, Ashwani
    Mittra, Shivani
    Suvarna, Viraj R.
    Athalye, Sandeep N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
12345